Aug 2018
Latest data shows that since it became easier for doctors to prescribe medicinal cannabis in New South Wales, 322 applications have been approved. While numbers are still relatively low compared to Canada or America, new processes in Australia have had a big impact, and for the first time, the total number of medicinal cannabis’ patients in Australia has reached 1,000. Read the article here.
One of ANTG’s proprietary medicinal cannabis strains, EVE Cannabis Indica, has been listed on the Australian Register of Therapeutic Goods (ARTG). The ARTG is a reference of therapeutic goods that can lawfully be supplied in or exported from Australia.
In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.
What’s most important in business – purpose or profit? At ANTG we get to achieve both.
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.
LEARN ABOUT ANTG HERE >